• Home/
  • News/
  • First Cost, Time-Effective ‘CRISPR’ Test For COVID-19 Gets Nod For Commercial Launch

News

First Cost, Time-Effective ‘CRISPR’ Test For COVID-19 Gets Nod For Commercial Launch

Director General Dr Shekhar Mande informed that a team of young scientists have developed a paper-based diagnostic kit which is called now FELUDA for COVID-19 test

First Cost, Time-Effective ‘CRISPR’ Test For COVID-19 Gets Nod For Commercial Launch
Highlights
  • FELUDA test kit only takes 45 minutes compared to the RT-PCR test for COVID
  • FELUDA test kit does not require any heavy equipment like RT-PCR
  • FELUDA test strip kit can be moved even to villages for testing people

New Delhi: The Drugs Controller General of India (DCGI) has given approval to the Tata Group for the launch of India’s first Clustered Regularly Interspaced Short Palindromic (CRISPR) Covid-19 test for commercial launch. The test is powered by Council of Scientific and Industrial Research’s Institute of Genomics and Integrative Biology (CSIR-IGIB) FELUDA, which is an acronym for the FNCAS9 Editor-Limited Uniform Detection Assay. A team of young scientists, have developed this 45 minutes cost-effective paper-based kit for Covid test, CSIR Director-General Dr Shekhar Mande said on Sunday (September 20).

Also Read: A COVID-19 Test That Can Give Result in 30 Minutes, Awaits ICMR Approval

FELUDA test kit only takes 45 minutes compared to the COVID test whereas a RT-PCR takes long hours and this COVID-19 testing kit is cheaper than RT-PCR based test kit. So in terms of time cost and accuracy FELUDA test kit is best. Another advantage is that it does not require any heavy equipment like RT-PCR, Dr Mande told ANI.

He said a laboratory in Delhi’s CSIR-IGIB has been working on CRISPR-based detection kit because they had its prior experience in working in this thing before the COVID-19 pandemic came.

Also Read: Retest All COVID-19 Symptomatic Negative Cases Of Rapid Antigen Test Using RT-PCR Test: Centre

They were able to very quickly repurpose the thing for COVID and they have developed a paper-based Diagnostic kit which is called now FELUDA and that kit yesterday got approval from the Drug Controller of General India (DCGI) who is the regulatory authority for this and the kit is being commercialized by Tata sons. Tata sons who have approach DCGI for approval and yesterday receive the formal approval, he said.

Dr Mande said that they are expecting the FELUDA kit to reach the market shortly.

FELUDA test kit is very cost effective because many things it doesn’t require costly equipment, unlike RT-PCR. It does not require any chemical which is costly. It is very cost effective and in terms of the time, it is very quick. It can literally in 45 minutes finish the test, he said.

Dr Mande said FELUDA kit and RT-PCR kit is different in many ways and similar in some ways.

Also Read: IIIM Devises Novel Coronavirus Test Kit For Rapid Diagnosis Of COVID-19, Seeks ICMR Nod For It

He said another advantage is it does not require any heavy equipment like RT- PCR we can also put the testing kit in car tempos.

So we can move anywhere even villages and move them around and keep testing people. So these are the advantages of FELUDA test strip kit, he added.

“In diagnosis, there are three principles of components diagnosis has to be rapid; the test has to be cheap and affordable at the diagnosis. It has to be accurate, which is the most paramount important thing that what we look for in today’s date. In the field, RT-PCR is a gold standard and FELUDA does not compromise on the accuracy of it so it’s as good as RT-PCR test. That is why we are very confident on this FELUDA test strip,” he said.

FELUDA is a fictitious character from Satyajit Ray’s film this is some sort of a detective and there are competing test. What we develop paper-based test there also been developed some part of the world and one of the groups have given name Sherlock so we thought Sherlock is another fictitious character so we thought FELUDA would actually match that. FELUDA is an Indian name Satyajit Rays very showcase name so we thought we give FELUDA name to this test strip, he added.

Also Read: Scientists Develop Portable, Point-Of-Care COVID-19 Test Which May Boost Testing

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.) 

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene.  

[corona_data_new]

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *